NasdaqCM:AHPI

Stock Analysis Report

Allied Healthcare Products

Executive Summary

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.

Share Price & News

How has Allied Healthcare Products's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.1%

AHPI

1.7%

US Medical Equipment

2.3%

US Market


1 Year Return

-31.2%

AHPI

10.1%

US Medical Equipment

5.6%

US Market

Return vs Industry: AHPI underperformed the US Medical Equipment industry which returned 10.1% over the past year.

Return vs Market: AHPI underperformed the US Market which returned 5.6% over the past year.


Shareholder returns

AHPIIndustryMarket
7 Day3.1%1.7%2.3%
30 Day-0.7%-1.7%-1.0%
90 Day-14.0%-1.7%-0.7%
1 Year-31.2%-31.2%11.0%10.1%7.9%5.6%
3 Year-28.4%-28.4%70.4%65.2%45.6%36.3%
5 Year-66.7%-66.7%128.5%103.2%65.8%47.6%

Price Volatility Vs. Market

How volatile is Allied Healthcare Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allied Healthcare Products undervalued compared to its fair value and its price relative to the market?

0.47x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: AHPI ($1.39) is trading above our estimate of fair value ($0.88)

Significantly Undervalued: AHPI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AHPI is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: AHPI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate AHPI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AHPI is good value based on its PB Ratio (0.5x) compared to the US Medical Equipment industry average (3.7x).


Next Steps

Future Growth

How is Allied Healthcare Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allied Healthcare Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Allied Healthcare Products performed over the past 5 years?

-0.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: AHPI is unprofitable, and losses have increased over the past 5 years at a rate of -0.4% per year.

Accelerating Growth: Unable to compare AHPI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AHPI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).


Return on Equity

High ROE: AHPI has a negative Return on Equity (-17.74%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: AHPI is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: AHPI is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Allied Healthcare Products's financial position?


Financial Position Analysis

Short Term Liabilities: AHPI's short term assets ($11.0M) exceeds its short term liabilities ($3.6M)

Long Term Liabilities: AHPI has no long term liabilities


Debt to Equity History and Analysis

Debt Level: AHPI is debt free.

Reducing Debt: AHPI had no debt 5 years ago.


Balance Sheet

Inventory Level: AHPI has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if AHPI's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable AHPI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: AHPI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 17.9% per year.


Next Steps

Dividend

What is Allied Healthcare Products's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate AHPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate AHPI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if AHPI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AHPI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AHPI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Allied Healthcare Products's salary, the management and board of directors tenure and is there insider trading?

18.3yrs

Average management tenure


CEO

Earl Refsland (76yo)

20.1yrs

Tenure

US$502,491

Compensation

Mr. Earl R. Refsland has been the President and Chief Executive Officer at Allied Healthcare Products Inc. since September 1999. From May 1995 to March 1998, Mr. Refsland served as the President and Chief  ...


CEO Compensation Analysis

Compensation vs. Market: Earl's total compensation ($USD502.49K) is about average for companies of similar size in the US market ($USD493.00K).

Compensation vs Earnings: Earl's compensation has been consistent with company performance over the past year.


Management Age and Tenure

18.3yrs

Average Tenure

60yo

Average Age

Experienced Management: AHPI's management team is seasoned and experienced (18.3 years average tenure).


Board Age and Tenure

15.7yrs

Average Tenure

75yo

Average Age

Experienced Board: AHPI's board of directors are seasoned and experienced ( 15.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Earl Refsland (76yo)

    CEO, President & Director

    • Tenure: 20.1yrs
    • Compensation: US$502.49k
  • Daniel Dunn (60yo)

    VP of Finance

    • Tenure: 18.3yrs
    • Compensation: US$255.78k
  • Andrew Riley (43yo)

    Vice President of Operations

    • Tenure: 5.3yrs
    • Compensation: US$230.35k

Board Members

  • John Weil (78yo)

    Independent Chairman

    • Tenure: 0yrs
    • Compensation: US$25.77k
  • Earl Refsland (76yo)

    CEO, President & Director

    • Tenure: 20.1yrs
    • Compensation: US$502.49k
  • Joseph Root (74yo)

    Independent Director

    • Tenure: 13yrs
    • Compensation: US$26.47k
  • Judy Graves (72yo)

    Independent Director

    • Tenure: 15.7yrs
    • Compensation: US$27.47k

Company Information

Allied Healthcare Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allied Healthcare Products, Inc.
  • Ticker: AHPI
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$5.579m
  • Shares outstanding: 4.01m
  • Website: https://www.alliedhpi.com

Number of Employees


Location

  • Allied Healthcare Products, Inc.
  • 1720 Sublette Avenue
  • St. Louis
  • Missouri
  • 63110
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AHPINasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJan 1992

Biography

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respirat ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/16 23:32
End of Day Share Price2019/10/16 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.